Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Irritable Bowel Syndrome, July 2022

Free Subscription


Abstracts

Retrieve all available abstracts of the following 74 articles:
HTML format


 

Single Articles

  1. GROENENDIJK DW, Witteman BJ, Mulder BC
    The Experiences of Female IBS Patients Concerning Physical Activity as Treatment Modality: A Qualitative Study.
    Qual Health Res. 2022 Jun 30:10497323221110109. doi: 10.1177/10497323221110109.
    PubMed    
    Abstract available

  2. REZAZADEGAN M, Shahdadian F, Soheilipour M, Tarrahi MJ, et al
    Zinc nutritional status, mood states and quality of life in diarrhea-predominant irritable bowel syndrome: a case-control study.
    Sci Rep. 2022;12:11002.
    PubMed    
    Abstract available

  3. NUNAN D, Cai T, Gardener AD, Ordonez-Mena JM, et al
    Physical activity for treatment of irritable bowel syndrome.
    Cochrane Database Syst Rev. 2022;6:CD011497.
    PubMed    
    Abstract available

  4. ONGARO G, Ballou S, Kube T, Haas J, et al
    Doctors Speak: A Qualitative Study of Physicians' Prescribing of Antidepressants in Functional Bowel Disorders.
    Cult Med Psychiatry. 2022 Jun 28. pii: 10.1007/s11013-022-09795.
    PubMed    
    Abstract available

  5. QUIGLEY EMM
    Gastrointestinal effects of diets low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols.
    Curr Opin Clin Nutr Metab Care. 2022;25:260-264.
    PubMed    
    Abstract available

  6. PRICE SJ, Gibson N, Hamilton WT, Bostock J, et al
    Diagnoses after newly recorded abdominal pain in primary care: observational cohort study.
    Br J Gen Pract. 2022 Apr 20. pii: BJGP.2021.0709. doi: 10.3399/BJGP.2021.0709.
    PubMed    
    Abstract available

  7. HURYCH J, Vejmelka J, Hlinakova L, Kramna L, et al
    Protocol for faecal microbiota transplantation in irritable bowel syndrome: the MISCEAT study - a randomised, double-blind cross-over study using mixed microbiota from healthy donors.
    BMJ Open. 2022;12:e056594.
    PubMed    
    Abstract available

  8. WANG N, Liu X, Ye W, Shi Z, et al
    Impact of shift work on irritable bowel syndrome and functional dyspepsia: A meta-analysis.
    Medicine (Baltimore). 2022;101:e29211.
    PubMed    
    Abstract available

  9. BOGGS KB, Edmonds K, Cifuentes-Munoz N, El Najjar F, et al
    Human Metapneumovirus Phosphoprotein Independently Drives Phase Separation and Recruits Nucleoprotein to Liquid-Like Bodies.
    mBio. 2022;13:e0109922.
    PubMed    
    Abstract available

  10. MAZZOLA M, Bertoglio CL, Giani A, Zironda A, et al
    Novel biodegradable internal stent as a mitigation strategy in high-risk pancreaticojejunostomy: technical notes and preliminary results.
    Surg Today. 2022;52:1115-1119.
    PubMed    
    Abstract available

  11. AUSTHOF E, Bell ML, Riddle MS, Catalfamo C, et al
    Persisting gastrointestinal symptoms and post-infectious irritable bowel syndrome following SARS-CoV-2 infection: results from the Arizona CoVHORT.
    Epidemiol Infect. 2022 Jul 8:1-22. doi: 10.1017/S0950268822001200.
    PubMed    


  12. NISHIYAMA J, Abe T, Imaizumi S, Yamane A, et al
    Characteristics of outpatients with functional somatic syndromes at a university hospital's general medicine clinic.
    J Gen Fam Med. 2022;23:268-274.
    PubMed    
    Abstract available

  13. BERENS S, Dong Y, Fritz N, Walstab J, et al
    Serotonin type 3 receptor subunit gene polymorphisms associated with psychosomatic symptoms in irritable bowel syndrome: A multicenter retrospective study.
    World J Gastroenterol. 2022;28:2334-2349.
    PubMed    
    Abstract available

  14. JIANG X, Guo X, Zhou J, Ye S, et al
    Acupuncture and Moxibustion in the Treatment of Adult Diarrhea Irritable Bowel Syndrome: A Network Meta-analysis.
    Comput Math Methods Med. 2022;2022:9919839.
    PubMed    
    Abstract available

  15. CREED F
    Risk Factors for Self-reported Irritable Bowel Syndrome With Prior Psychiatric Disorder: The Lifelines Cohort Study.
    J Neurogastroenterol Motil. 2022;28:442-453.
    PubMed    
    Abstract available

  16. SULTAN N, Varney JE, Halmos EP, Biesiekierski JR, et al
    How to Implement the 3-Phase FODMAP Diet Into Gastroenterological Practice.
    J Neurogastroenterol Motil. 2022;28:343-356.
    PubMed    
    Abstract available

  17. LEE HS
    Irritable Bowel Syndrome or Psychiatric Disorders: Which Comes First?
    J Neurogastroenterol Motil. 2022;28:335-336.
    PubMed    


  18. OLYAIEE A, Sadeghi A, Yadegar A, Mirsamadi ES, et al
    Gut Microbiota Shifting in Irritable Bowel Syndrome: The Mysterious Role of Blastocystis sp.
    Front Med (Lausanne). 2022;9:890127.
    PubMed    
    Abstract available

  19. ZHENG X, Zhi MJ, Zhao LL, Chen L, et al
    [Effect mechanism of blistering moxibustion on visceral hypersensitivity of irritable bowel syndrome in mice based on 5-HT signal pathway].
    Zhongguo Zhen Jiu. 2022;42:773-8.
    PubMed    
    Abstract available

  20. DE BENEDITTIS G
    Hypnobiome: A New, Potential Frontier of Hypnotherapy in the Treatment of Irritable Bowel Syndrome-A Narrative Review of the Literature.
    Int J Clin Exp Hypn. 2022 Jul 6:1-14. doi: 10.1080/00207144.2022.2094269.
    PubMed    


  21. NGUYEN M, Palm NW
    Gut instincts in neuroimmunity from the eighteenth to twenty-first centuries.
    Semin Immunopathol. 2022 Jul 4. pii: 10.1007/s00281-022-00948.
    PubMed    
    Abstract available

  22. TORRICO TJ, Kaur S, Dayal M, Eagala P, et al
    Lubiprostone for the Treatment of Clozapine-Induced Constipation: A Case Series.
    Cureus. 2022;14:e25576.
    PubMed    
    Abstract available

  23. WANNER C, Kimonis V, Politei J, Warnock DG, et al
    Understanding and modifying Fabry disease: Rationale and design of a pivotal Phase 3 study and results from a patient-reported outcome validation study.
    Mol Genet Metab Rep. 2022;31:100862.
    PubMed    
    Abstract available

  24. SAYUK GS, North CS, Pollio DE, Gott BM, et al
    Episodic Memories Among Irritable Bowel Syndrome (IBS) Patients: An Important Aspect of the IBS Symptom Experience.
    Front Pain Res (Lausanne). 2022;3:892313.
    PubMed    
    Abstract available

  25. SIMONS J, Shajee U, Palsson O, Simren M, et al
    Disorders of gut-brain interaction: Highly prevalent and burdensome yet under-taught within medical education.
    United European Gastroenterol J. 2022 Jul 3. doi: 10.1002/ueg2.12271.
    PubMed    
    Abstract available

  26. GHAHRAMANI Z E, Grimm PD, Eary KJ, Swearengen MP, et al
    Three-dimensional echo decorrelation monitoring of radiofrequency ablation in ex vivo bovine liver.
    J Acoust Soc Am. 2022;151:3907.
    PubMed    
    Abstract available

  27. BARKER KH, Higham JP, Pattison LA, Taylor TS, et al
    Sensitisation of colonic nociceptors by TNFalpha is dependent on TNFR1 expression and p38 MAPK activity.
    J Physiol. 2022 Jul 1. doi: 10.1113/JP283170.
    PubMed    
    Abstract available

  28. ALHARBI W, Jahan S
    Prevalence and Associated Risk Factors of Irritable Bowel Syndrome Among Female Secondary School students in Ar Rass City, Qassim Region.
    Health Psychol Res. 2022;10:35482.
    PubMed    
    Abstract available

  29. DAS A, Razon AH, Ahmad T, Paul DK, et al
    Prevalence of irritable bowel syndrome and its associated risk factors among university students of Bangladesh.
    JGH Open. 2022;6:421-426.
    PubMed    
    Abstract available

  30. MELCHIOR C, Colomier E, Trindade IA, Khadija M, et al
    Irritable bowel syndrome: Factors of importance for disease-specific quality of life.
    United European Gastroenterol J. 2022 Jul 13. doi: 10.1002/ueg2.12277.
    PubMed    
    Abstract available

  31. VELASCO-BENITEZ CA, Collazos-Saa LI, Garcia-Perdomo HA
    A SYSTEMATIC REVIEW AND META-ANALYSIS IN SCHOOLCHILDREN AND ADOLESCENTS WITH FUNCTIONAL GASTROINTESTINAL DISORDERS ACCORDING TO ROME IV CRITERIA.
    Arq Gastroenterol. 2022;59:304-313.
    PubMed    
    Abstract available

  32. MARTURANO M, Campagna G, Gaetani E, Natale F, et al
    500 EFFECTS OF COVID-19 PANDEMICS ON SYMPTOMS AND QUALITY OF LIFE IN PATIENTS AFFECTED BY INTERSTITIAL CYSTITIS/PAINFUL BLADDER SYNDROME (IC/PBS) AND IRRITABLE BOWEL SYNDROME (IBS).
    Continence (Amst). 2022;2:1-2.
    PubMed    


  33. ALSHAMMARI H, Al-Saeed E, Ahmed Z, Aslanpour Z, et al
    Prevalence and Predictors of Potentially Inappropriate Medications Among Patients Aged >/=65 Years on Hospital Admissions in Kuwait.
    Clin Interv Aging. 2022;17:1025-1036.
    PubMed    
    Abstract available

  34. SASEGBON A, Hasan SS, Whorwell PJ, Vasant DH, et al
    Experience and clinical efficacy of gut-directed hypnotherapy in an Asian population with refractory irritable bowel syndrome.
    JGH Open. 2022;6:447-453.
    PubMed    
    Abstract available

  35. PEERY AF, Keku TO, Galanko JA, Sandler RS, et al
    Colonic Diverticulosis Is Not Associated With Painful Abdominal Symptoms in a US Population.
    Gastro Hep Adv. 2022;1:659-665.
    PubMed    
    Abstract available

  36. JAIN M, Kumar GSS, Gowrishankar R, Srinivas M, et al
    Defaecation disorders among information technology personnel: A cross-sectional study.
    Natl Med J India. 2021;34:333-336.
    PubMed    
    Abstract available

  37. AHAMAD A, Tehreem B, Farooqi M, Maramara B, et al
    Case report and literature review: double jeopardy - Exophiala dermatitidis and Mycobacterium canariasense central line-associated bloodstream infection in a patient.
    Access Microbiol. 2022;4:000347.
    PubMed    
    Abstract available

  38. ALSUBAIE MA, Alkhalifah HA, Ali AH, Bahabri MA, et al
    Adverse Childhood Experiences and Their Effect on Irritable Bowel Syndrome Among Saudi Arabian Adults.
    Cureus. 2022;14:e25791.
    PubMed    
    Abstract available

  39. SHUTE A, Bihan DG, Lewis IA, Nasser Y, et al
    Metabolomics: The Key to Unraveling the Role of the Microbiome in Visceral Pain Neurotransmission.
    Front Neurosci. 2022;16:917197.
    PubMed    
    Abstract available

  40. TUCK CJ, Sultan N, Tonkovic M, Biesiekierski JR, et al
    Orthorexia nervosa is a concern in gastroenterology: A scoping review.
    Neurogastroenterol Motil. 2022 Jul 10:e14427. doi: 10.1111/nmo.14427.
    PubMed    
    Abstract available

  41. SUNDAS A, Sampath H, Lamtha SC, Soohinda G, et al
    Psychosocial quality-of-life correlates in functional gastrointestinal disorders.
    Rev Gastroenterol Mex (Engl Ed). 2022 Jul 6. pii: S2255-534X(22)00082.
    PubMed    
    Abstract available

  42. ISMAIL MH, Abbas SK, Molan AL
    Prevalence and subtype diversity of Blastocystis sp. in an Iraqi population with and without irritable bowel syndrome (IBS).
    Ann Parasitol. 2022;68:275-286.
    PubMed    
    Abstract available

  43. CECCHERINI C, Daniotti S, Bearzi C, Re I, et al
    Evaluating the Efficacy of Probiotics in IBS Treatment Using a Systematic Review of Clinical Trials and Multi-Criteria Decision Analysis.
    Nutrients. 2022;14.
    PubMed    
    Abstract available

  44. ABUELAZM M, Muhammad S, Gamal M, Labieb F, et al
    The Effect of Vitamin D Supplementation on the Severity of Symptoms and the Quality of Life in Irritable Bowel Syndrome Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Nutrients. 2022;14.
    PubMed    
    Abstract available

  45. BELLINI M, Tosetti C, Rettura F, Morganti R, et al
    Translational Gap between Guidelines and Clinical Medicine: The Viewpoint of Italian General Practitioners in the Management of IBS.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  46. BANCIU DD, Cretoiu D, Cretoiu SM, Banciu A, et al
    Telocytes' Role in Modulating Gut Motility Function and Development: Medical Hypotheses and Literature Review.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  47. PARDO-CAMACHO C, Ganda Mall JP, Martinez C, Pigrau M, et al
    Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome: Jejunal Barrier Alterations Underlying Clinical Manifestations.
    Cells. 2022;11.
    PubMed    
    Abstract available

  48. ALDERSON SL, Wright-Hughes A, Ford AC, Farrin A, et al
    Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary care.
    Trials. 2022;23:552.
    PubMed    
    Abstract available

  49. LI Y, Peng S, Liang F, Liu S, et al
    Effectiveness of acupuncture for irritable bowel syndrome: Protocol for a scoping review of systematic reviews and meta-analyses.
    Medicine (Baltimore). 2022;101:e29218.
    PubMed    
    Abstract available

  50. EL SHARAWY SM, Amer IF, Elkadeem MZ
    Irritable bowel syndrome in Egyptian medical students, prevalence and associated factors: a cross-sectional study.
    Pan Afr Med J. 2022;41:311.
    PubMed    
    Abstract available

  51. GUO J, Chen L, Wang YH, Song YF, et al
    Electroacupuncture Attenuates Post-Inflammatory IBS-Associated Visceral and Somatic Hypersensitivity and Correlates With the Regulatory Mechanism of Epac1-Piezo2 Axis.
    Front Endocrinol (Lausanne). 2022;13:918652.
    PubMed    
    Abstract available

  52. CABALLERO N, Marin I, Riu F, Leal C, et al
    Effect of intracolonic volume on gastric sensory-motor responses in constipation-predominant irritable bowel syndrome.
    Neurogastroenterol Motil. 2022 Jul 21:e14433. doi: 10.1111/nmo.14433.
    PubMed    
    Abstract available

  53. JACOBS JW, Leadbetter MR, Bell N, Koo-McCoy S, et al
    Discovery of Tenapanor: A First-in-Class Minimally Systemic Inhibitor of Intestinal Na(+)/H(+) Exchanger Isoform 3.
    ACS Med Chem Lett. 2022;13:1043-1051.
    PubMed    
    Abstract available

  54. ADEWUYI EO, O'Brien EK, Nyholt DR, Porter T, et al
    A large-scale genome-wide cross-trait analysis reveals shared genetic architecture between Alzheimer's disease and gastrointestinal tract disorders.
    Commun Biol. 2022;5:691.
    PubMed    
    Abstract available

  55. GENTILE M, De Luca V, Patalano R, Laudisio D, et al
    Proposal for innovative and integrated approaches to the unmet needs of irritable bowel syndrome patients. Preliminary Vigour report.
    Ann Ital Chir. 2022;11.
    PubMed    
    Abstract available

  56. GNONI M, Beas R, Grewal R, Diaz-Pardave C, et al
    Scurvy: an often misdiagnosed condition in the modern days?
    Folia Med (Plovdiv). 2022;64:543-546.
    PubMed    
    Abstract available

  57. VAN DER GEEST AM, Schukking I, Brummer RJM, van de Burgwal LHM, et al
    Comparing probiotic and drug interventions in irritable bowel syndrome: a meta-analysis of randomised controlled trials.
    Benef Microbes. 2022 Jul 18:1-12. doi: 10.3920/BM2021.0123.
    PubMed    
    Abstract available

  58. VAN DER GEEST AM, Schukking I, Brummer RJM, Pieterse H, et al
    Inadequate safety reporting in the publications of randomised clinical trials in irritable bowel syndrome: drug versus probiotic interventions.
    Benef Microbes. 2022 Jul 18:1-10. doi: 10.3920/BM2021.0124.
    PubMed    
    Abstract available

  59. GU Q, Lei Y, Wu J, He T, et al
    NUCB2/Nesfatin-1 Regulation of Chronic Visceral Hyperalgesia.
    Appl Bionics Biomech. 2022;2022:4079533.
    PubMed    
    Abstract available

  60. LIU Y, Liao R, Qiang Z, Yang W, et al
    Exogenous H2S promotes ion channel reconstruction to regulate colonic motility in rats with dinitrobenzene sulfonic acid-induced colitis.
    Ann Transl Med. 2022;10:681.
    PubMed    
    Abstract available

  61. OKUMURA T, Nozu T, Ishioh M, Igarashi S, et al
    Oxytocin acts centrally in the brain to improve leaky gut through the vagus nerve and a cannabinoid signaling in rats.
    Physiol Behav. 2022;254:113914.
    PubMed    
    Abstract available

  62. WHELAN K, Staudacher H
    Low FODMAP diet in irritable bowel syndrome: a review of recent clinical trials and meta-analyses.
    Curr Opin Clin Nutr Metab Care. 2022 Jul 16. pii: 00075197-990000000-00017.
    PubMed    
    Abstract available

  63. HAMAZAKI M, Sawada T, Yamamura T, Maeda K, et al
    Fecal microbiota transplantation in the treatment of irritable bowel syndrome: a single-center prospective study in Japan.
    BMC Gastroenterol. 2022;22:342.
    PubMed    
    Abstract available

  64. STALLER K, Paz M, Rones R, Macklin EA, et al
    Virtual Tai Chi program for patients with irritable bowel syndrome with constipation: Proof-of-concept feasibility trial.
    Neurogastroenterol Motil. 2022 Jul 14:e14429. doi: 10.1111/nmo.14429.
    PubMed    
    Abstract available

  65. ZHANG T, Ma X, Tian W, Zhang J, et al
    Global Research Trends in Irritable Bowel Syndrome: A Bibliometric and Visualized Study.
    Front Med (Lausanne). 2022;9:922063.
    PubMed    
    Abstract available

  66. LI Y, Zhang T, Sun J, Liu N, et al
    Fecal Microbiota Transplantation and Health Outcomes: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials.
    Front Cell Infect Microbiol. 2022;12:899845.
    PubMed    
    Abstract available

  67. SMITH SJ, Sichlau M, Sewall LE, Smith BH, et al
    An online survey of pelvic congestion support group members regarding comorbid symptoms and syndromes.
    Phlebology. 2022 Jul 13:2683555221112567. doi: 10.1177/02683555221112567.
    PubMed    
    Abstract available

  68. LI ZC, Yan J, Zhang S, Liang C, et al
    Glioma survival prediction from whole-brain MRI without tumor segmentation using deep attention network: a multicenter study.
    Eur Radiol. 2022;32:5719-5729.
    PubMed    
    Abstract available

  69. GOODOORY VC, Ng CE, Black CJ, Ford AC, et al
    Impact of Rome IV Irritable Bowel Syndrome on Work and Activities of Daily Living.
    Aliment Pharmacol Ther. 2022 Jul 6. doi: 10.1111/apt.17132.
    PubMed    
    Abstract available

  70. BIESIEKIERSKI JR, Manning LP, Murray HB, Vlaeyen JWS, et al
    Review article: Exclude or expose? The paradox of conceptually opposite treatments for irritable bowel syndrome.
    Aliment Pharmacol Ther. 2022 Jul 1. doi: 10.1111/apt.17111.
    PubMed    
    Abstract available

  71. VOLLEBREGT PF, Wiklendt L, Burgell RE, Chaichanavichkij P, et al
    Abnormal Perception of Urge to Defecate: An Important Pathophysiological Mechanism in Women With Chronic Constipation.
    Am J Gastroenterol. 2022;117:1125-1136.
    PubMed    
    Abstract available

  72. SHAH ED
    Delta Variant: Expanding the Indication for Eluxadoline to Bile Acid Diarrhea.
    Dig Dis Sci. 2022 Feb 5. pii: 10.1007/s10620-022-07386.
    PubMed    


  73. HOWELL CA, Kemppinen A, Allgar V, Dodd M, et al
    Double-blinded randomised placebo controlled trial of enterosgel (polymethylsiloxane polyhydrate) for the treatment of IBS with diarrhoea (IBS-D).
    Gut. 2022 Jun 27. pii: gutjnl-2022-327293. doi: 10.1136/gutjnl-2022-327293.
    PubMed    
    Abstract available

  74. REXWINKEL R, Bovendeert JFM, Rutten JMTM, Frankenhuis C, et al
    Long-Term Follow-up of Individual Therapist Delivered and Standardized Hypnotherapy Recordings in Pediatric Irritable Bowel Syndrome or Functional Abdominal Pain.
    J Pediatr Gastroenterol Nutr. 2022;75:24-29.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;